Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Po
Issuer: Sernova Corp. / Key word(s): Study results/Study10.01.2023 / 13:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes Fi...
Source: pharmiweb.com